Literature DB >> 12471601

Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.

Jeremy L Jenkins1, Richard Y T Kao, Robert Shapiro.   

Abstract

"Hit lists" generated by high-throughput screening (HTS) typically contain a large percentage of false positives, making follow-up assays necessary to distinguish active from inactive substances. Here we present a method for improving the accuracy of HTS hit lists by computationally based virtual screening (VS) of the corresponding chemical libraries and selecting hits by HTS/VS consensus. This approach was applied in a case study on the target-enzyme angiogenin, a potent inducer of angiogenesis. In conjunction with HTS of the National Cancer Institute Diversity Set and ChemBridge DIVERSet E (approximately 18,000 compounds total), VS was performed with two flexible library docking/scoring methods, DockVision/Ludi and GOLD. Analysis of the results reveals that dramatic enrichment of the HTS hit rate can be achieved by selecting compounds in consensus with one or both of the VS functions. For example, HTS hits ranked in the top 2% by GOLD included 42% of the true hits, but only 8% of the false positives; this represents a sixfold enrichment over the HTS hit rate. Notably, the HTS/VS method was effective in selecting out inhibitors with midmicromolar dissociation constants typical of leads commonly obtained in primary screens. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12471601     DOI: 10.1002/prot.10270

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  20 in total

1.  G protein-coupled receptors: in silico drug discovery in 3D.

Authors:  Oren M Becker; Yael Marantz; Sharon Shacham; Boaz Inbal; Alexander Heifetz; Ori Kalid; Shay Bar-Haim; Dora Warshaviak; Merav Fichman; Silvia Noiman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

2.  Application of a sequential multicomponent assembly process/huisgen cycloaddition strategy to the preparation of libraries of 1,2,3-triazole-fused 1,4-benzodiazepines.

Authors:  James R Donald; Rebekah R Wood; Stephen F Martin
Journal:  ACS Comb Sci       Date:  2012-02-01       Impact factor: 3.784

3.  Here be dragons: docking and screening in an uncharted region of chemical space.

Authors:  Ruth Brenk; John J Irwin; Brian K Shoichet
Journal:  J Biomol Screen       Date:  2005-09-16

4.  Design of ligand binding to an engineered protein cavity using virtual screening and thermal up-shift evaluation.

Authors:  Claudia Machicado; Jon López-Llano; Santiago Cuesta-López; Marta Bueno; Javier Sancho
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

Review 5.  Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go.

Authors:  N Moitessier; P Englebienne; D Lee; J Lawandi; C R Corbeil
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 6.  Novel paradigms for drug discovery: computational multitarget screening.

Authors:  Ekachai Jenwitheesuk; Jeremy A Horst; Kasey L Rivas; Wesley C Van Voorhis; Ram Samudrala
Journal:  Trends Pharmacol Sci       Date:  2008-01-10       Impact factor: 14.819

7.  Comparative virtual screening and novelty detection for NMDA-GlycineB antagonists.

Authors:  Bjoern A Krueger; Tanja Weil; Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

8.  Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer.

Authors:  Pankaj Kumar Singh; Om Silakari
Journal:  J Mol Model       Date:  2018-10-20       Impact factor: 1.810

Review 9.  How to do an evaluation: pitfalls and traps.

Authors:  Paul C D Hawkins; Gregory L Warren; A Geoffrey Skillman; Anthony Nicholls
Journal:  J Comput Aided Mol Des       Date:  2008-01-23       Impact factor: 3.686

10.  IspE inhibitors identified by a combination of in silico and in vitro high-throughput screening.

Authors:  Naomi Tidten-Luksch; Raffaella Grimaldi; Leah S Torrie; Julie A Frearson; William N Hunter; Ruth Brenk
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.